Emerging Landscape

Psilocybin is one of the most effective psychedelics for the treatment of conditions such as treatment-resistant depression, anxiety, PTSD and depression.

These natural benefits, known for years to traditional societies, are only now are being researched after decades of stigmatization and inaccurate scaremongering.

The world’s leading academic institutions are compiling a growing amount of research into the benefits of psilocybin. Universities such as Imperial College London, the NYU Grossman School of Medicine and Johns Hopkins University, and medical research bodies including the Heffter Research Institute, the Beckley Foundation and MAPS have all contributed to this.

• Griffiths, Roland R., et al. "Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance." Psychopharmacology 187.3 (2006): 268-283.
• Carhart-Harris, Robin L., et al. "Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms." Scientific reports 7.1 (2017): 1-11.
• Carhart-Harris, Robin L., et al. "Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study." The Lancet Psychiatry 3.7 (2016): 619-627.
• Carhart-Harris, Robin L., et al. "Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin." Proceedings of the National Academy of Sciences 109.6 (2012): 2138-2143.
• Carhart-Harris, R. L., et al. "Psilocybin with psychological support for treatment-resistant depression: six-month follow-up." Psychopharmacology 235.2 (2018): 399-408.
• Roseman, Leor, et al. "Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression." Neuropharmacology 142 (2018): 263-269.
• Stroud, J. B., et al. "Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression." Psychopharmacology 235.2 (2018): 459-466.
• Carhart-Harris, Robin L., et al. "Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin." The British Journal of Psychiatry 200.3 (2012): 238-244.
• Nutt, David. "Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future." J Psychopharmacol 30 (2016): 1163-1164.
• Ross, Stephen. "Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress." International Review of Psychiatry 30.4 (2018): 317-330.
• Swift, Thomas C., et al. "Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress." Journal of Humanistic Psychology 57.5 (2017): 488-519.